The REVEAL-1 data show that patients who underwent a single Revita procedure maintained approximately 78% of their prior GLP-1-induced weight loss at one year, with 33% of patients continuing to lose weight one year after discontinuing a GLP-1
Medicaid spending on GLP-1s for all conditions increased from $597.3 million for about 755,000 prescriptions in 2019, to $3.9 billion for 3.8 million prescriptions in 2023, according to KFF
If you're switching from another provider or from Mounjaro, you may not need to start at 0.25mg
Corticosteroids (prednisone, dexamethasone, and similar) : These suppress growth hormone release
People taking a GLP-1, they found, had a noticeably greater chance of being diagnosed with smell or taste problems than those taking a different diabetes drug
Through lifes cycles, changes, and transitions, were here to help you make informed choices about your health.